EM-Kurunga probiotic complex 60 tabs x 0.25g

The symbiotic microflora of the EM-Kurunga® product synthesizes enzymes and biologically active substances in the intestine that suppress the growth of pathogenic and opportunistic microflora, thereby optimizing the saprophytic microbiotic structure of the intestine to the level of the individual norm, compensating for dysbiotic conditions. EM-Kurunga® helps to normalize the vital activity of the cavity and parietal microbiota, reducing the amount of pathogenic deposits. Against the background of the restoration of the physiological state of the intestinal epithelium, its protective barrier function increases, and endogenous intoxication of the body decreases. Under conditions of restoration of the saprophytic intestinal flora, the synthesis of endogenous vitamins and the physiological level of absorption of exogenous macro- and micronutrients (nutritional components of food, vitamins, other macro- and microelements, including Fe, Ca, Zn, Mg and biologically active substances) are optimized. Due to the produced lactic acid and its buffer salts, the acidity value of all sections of the gastrointestinal tract, regardless of the initial indicators, becomes physiological. EM-Kurunga® has a positive effect on the human immune system, immunogenesis; improves the nutrient status and homeostasis of the body; improves the quality of peripheral circulation; helps to reduce the influence or correct the risk factors of diseases of the gastrointestinal tract, cardiovascular and musculoskeletal systems (prevention of angiopathies, atherosclerosis, arthritis and osteoporosis).
EM-Kurunga® is systemically involved in the physiological processes of the body, normalizing them; increases the body's resistance to harmful agents; acts as a biocatalyst of reparative and protective processes. Ingredients: Biologically active symbiotic microflora, peptides and oligopeptides (fractions of casein hydrolysate - milk protein), obtained as a result of the enzymatic effect on casein of the symbiosis of bifidobacteria, lactobacilli, acetic acid and lactic acid streptococci, propionic bacteria, lactostreptococci, milk yeast, etc. (patent for the invention of a method for preparing a peptide-containing product EM-Kurunga® No. 2524437). The product contains its own enzymes, amino acids (including essential ones), nutrients.
Method of application
For preventive and restorative purposes, EM-Kurunga® is taken before or during meals, with a small amount of warm liquid (water, milk).
Adults - 3-4 tablets per day;
children - 2 tablets per day. Adults are recommended to use the encapsulated form, since some bacteria may die in the acidic environment of the stomach.
In pediatric practice and gerontology, tablets are recommended, because the acidity of gastric juice in children and the elderly is low. The frequency and duration of taking EM-Kurunga® depends on the initial and current state of the body.
In acute intestinal infections, long-term intestinal dysfunction of unknown etiology; nonspecific ulcerative colitis; chronic colitis and enterocolitis; dysbacteriosis of various etiologies, including those caused by the use of antibiotics, inflammatory diseases of other organs and systems, the frequency of administration should be increased to 6-8 tablets per day. Reception - 7-9 days.
In case of constipation, take 6 tablets at night; after improvement of the condition, the dose can be reduced by half. With regular use of EM-Kurunga® in cancer patients before and after chemotherapy, vomiting and diarrhea are usually eliminated. At the same time, at the recovery and anti-relapse stage, the following frequency and dosage should be observed: 2 tablets every 1.5-2 hours; breaks - during sleep.
The most effective use of EM-Kurunga for prophylactic purposes is 3-4 tablets per day in the form of 2-4 courses per year for 30 days. To improve digestion and reduce the toxic load on the liver and kidneys, it can be taken regularly or periodically with meals.
It is advisable to take EM-Kurunga® prophylactically in combination with prebiotics (fiber, pectins, inulin). Early prevention of dysbacteriosis and immunopathy in newborns consists of taking EM-Kurunga® by pregnant and lactating women.

Indications
Violation of the intestinal microbiocenosis structure (including during and after treatment with antibiotics and sulfonamides, chemo- and radiation therapy, surgical interventions on the gastrointestinal tract); Malabsorption syndrome; Indigestion syndrome; Dyspepsia; Senile bowel syndrome (chronic atrophic gastroenterocolitis); Gastrointestinal disorders associated with intoxication, food poisoning; Changes in the functioning of the macroorganism associated with climate and diet changes (fasting, fasting); Chronic gastroenterocolitis; Hypoacid and anacid conditions; - enterogenic riskogenic conditions of the liver; cholecystitis; pancreatitis; Acute, chronic and allergic conditions of the skin and respiratory system; Dysfunctions of the pelvic organs and urogenital system; Autoimmune manifestations in the form of arthritis, arthrosis; Risky conditions of the cardiovascular system at all stages of their manifestation; Syndrome of hyperreactive and deviant behavior in children and adolescents; Recovery after treatment of salmonellosis (including in infants); Risk of oncological processes and neoplasms.